Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lupus Erythematosus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 290 pages

Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lupus Nephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 86 pages

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphoblastic Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 68 pages

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphocyte Activation...

May 2022 79 pages

Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lymphoproliferative Disorders Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 52 pages

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 41 pages

Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 226 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mole...

May 2022 36 pages

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Major Depressive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 153 pages

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Major Prion Protein...

May 2022 35 pages

Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Male Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 91 pages

Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Ascites Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 35 pages

Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Fibrous Histiocytoma Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 52 pages

Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 94 pages

Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Malignant Pleural Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Malignant Pleural Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Malignant Pleural Mesothelioma Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 125 pages

Mantle Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mantle Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mantle Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 301 pages

Maple Syrup Urine Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Maple Syrup Urine Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Maple Syrup Urine Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Marginal Zone B-cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 193 pages

Mast Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mast Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mast Cell Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 36 pages

Mast-Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mast-Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT...

May 2022 89 pages

Matrix Metalloproteinase (MMP or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Matrix Metalloproteinase (MMP or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Matrix Metalloproteinase (MMP or EC 3.4.24.)...

May 2022 72 pages

Medullary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Medullary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Medullary Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 77 pages

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer-Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer-Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 40 pages

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY MELAS Syndrome (Mitoc...

May 2022 42 pages

Melatonin Receptor Type 1A (MT1 or MTNR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Melatonin Receptor Type 1A (MT1 or MTNR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Melatonin Receptor Type 1A (MT1 or MTNR1A) Dru...

May 2022 42 pages

Melatonin Receptor Type 1B (MT2 or MTNR1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Melatonin Receptor Type 1B (MT2 or MTNR1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Melatonin Receptor Type 1B (MT2 or MTNR1B) Dru...

May 2022 41 pages

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Membra...

May 2022 41 pages

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Membranoproliferative Glomerulonephriti...

May 2022 38 pages

Membranous Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Membranous Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Membranous Glomerulonephritis Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 39 pages

Memory Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Memory Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Memory Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 41 pages

Meningioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Meningioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Meningioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 55 pages

Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Menopausal Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 51 pages

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mesothelin...

May 2022 37 pages

Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 58 pages

Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stag...

May 2022 120 pages

Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 38 pages

Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA...

May 2022 97 pages

Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stag...

May 2022 109 pages

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Hormone Re...

May 2022 292 pages

Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 60 pages

Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 100 pages

Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 231 pages

Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 84 pages

Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA...

May 2022 133 pages

Metastatic Transitional (Urothelial) Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Transitional (Urothelial) Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Transitional (Urothelial) Tract Cancer Drugs in Dev...

May 2022 120 pages

Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 64 pages

Methyl CpG Binding Protein 2 (MECP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Methyl CpG Binding Protein 2 (MECP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Methyl CpG Binding Protein 2 (MECP2) Drugs in Develo...

May 2022 39 pages

Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 41 pages

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 35 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...